[1] Colton CK. Implantable biohybrid artificial organs. Cell Transplant. 1995;4(4):415-436.[2] Kneser U, Stangenberg L, Ohnolz J, et al. Evaluation of processed bovine cancellous bone matrix seeded with syngenic osteoblasts in a critical size calvarial defect rat model. J Cell Mol Med. 2006;(10):695-707.[3] 裴国献,魏宽海.显微外科与血管化组织工程组织的构建[J].中华创伤骨科杂志,2004,6(4):361-363.[4] Herring M, Gardner A, Glover J. A single staged technique for seeding vascular grafts with autologous endothelium. Surgery. 1978;84(4):498-504.[5] Frerich B, Kurtz-Hoffmann J, Lindemann N, et al. Tissue engineering of vascularized bone and soft tissue transplants. Mund Kiefer Gesichtschir. 2000;4(suppl 2):490-495.[6] Soker S, Machado M, Atala A. Systems for therapeutic angiogenesis in tissue engineering. World J Urol. 2000;18 (1):10-18. [7] Rouwkema J, de Boer J, Van Blitterswijk CA. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng. 2006;12(9): 2685-2693.[8] Wang DS, Yamazaki K, Nohtomi K, et al. Increase of vascular endothelial growth factor mRNA expression by 1, 25-dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res. 1996;11(4):472-479.[9] Wang DS, Miura M, Demura H, et al. Anabolic effects of 1, 25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology. 1997;138(7):2953-2962.[10] Villars F, Bordenave L, Bareille R, et al. Effect of human endothelial cells on human bone marrow stromal cell phenotype: role of VEGF? J Cell Biochem. 2000; 79(4):672-685.[11] Villars F, Guillotin B, Amedee T, et al. Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. Am J Physiol Cell Physiol. 2002;282(4):775-785.[12] 杨志明,樊征夫,解慧琪,等.组织工程化人工骨血管化研究[J].中华显微外科杂志,2002,25(2):119-122.[13] Shi Q, Rafii S, Wu MH, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998;92(2):362-367.[14] Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001;107(11):1395-1402.[15] Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302): 964-967.[16] 吴雪晖,许建中,王序全,等.血管内皮祖细胞对组织工程骨成骨能力影响的实验研究[J].重庆医学,2006,35(22):2058-2062.[17] Zhu M, Strem BM. Endothelial progenitor cells-a new promise for angiogenesis in tissue engineering. 8th TESI Ann Meet, China: Shanghai, 2005.[18] Reyes M, Dudek A, Jahagirdar B, et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002;109(3):337-346.[19] Norrby K. Angiogenesis: new aspects relating to its initiation and control. APMIS. 1997;105(6):417-437.[20] Thurston G. Complementary action of VEGF and angiopoietin-1 on blood vessel growth and leakage. J Anat. 2002;200(6):575-580.[21] Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989;161(2): 851-858.[22] Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669-676.[23] Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med. 1999;77(7): 527- 543.[24] Kleinheinz J, Wiesmann HP, Stratmann U, et al. Evaluating angiogenesis and osteogenesis modified by vascular endothelial growth factor (VEGF). Mund Kiefer Gesichtschir. 2002;6(3): 175-182.[25] Peng H, Wright V, Usas A, et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest. 2002;110(6): 751-759.[26] Springer ML, Chen AS, Kraft PE, et al. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell. 1998;2(5):549-558.[27] Gospodarowicz D. Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature. 1974;249(453): 123-127.[28] Abraham JA, Mergia A, Whang JL, et al. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science. 1986;233(4763): 545-548.[29] Rifkin DB, Moscatelli D. Recent development in the cell biology of basic fibroblast growth factor. J Cell Biol. 1989; 109(1):1-6.[30] Ryuto M, Ono M, Izumi H, et al. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem. 1996; 271(45):28220-28228.[31] Wenger A, Stahl A, Weber H, et al. Modulation of in vitro angiogenesis in a three-dimenssional spheroidal coculture model for bone tissue engineering. Tissue Eng. 2004;10 (9-10):1536-1547.[32] Srivastava S, Terjun RL, Yang HT, et al. Basic fibroblast growth factor increases collateral blood flow in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2003; 285(3): H 1190-1197.[33] Kawaguchi H, Kurokawa T, Hanada K, et al. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocinology. 1994;135(2):774-781.[34] Perets A, Baruch Y, Weisbuch F, et al. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microshperes. J Biomed Mater Res A. 2003;65(4): 489-497.[35] Tabata Y, Ikada Y. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials. 1999;20(22):2169-2175.[36] Laham RJ, Sellke FW, Edelman ER, et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase 1 randomized, double-blind, placebo-controlled trial. Circulation. 1999; 100(18):1865-1871.[37] Yuksel E, Weinfeld AB, Cleek R, et al. Increased free fat graft survival with the long term local delivery of insulin-like growth factor-1, and basic fibroblast growth factor by PLGA/PEG microspheres. Plast Reconstru Surg. 2000;105(5):1712-1720.[38] 郑启新,郭晓东,刘勇,等.bFGF基因修饰的间充质干细胞/多孔β-TCP陶瓷复合移植修复兔节段性骨缺损[J].中国生物医学工程学报,2003,22(2):171-176.[39] Brey EM, Uriel S, Greisler HP, et al. Therapeutic neovascularization: contributions from bioengineering. Tissue Eng. 2005; 11(3-4):567-584.[40] Richardson TP, Peter MC, Ennett AB, et al. Polymeric system for dual growth factor delivery. Nat Biotechnol. 2001;19(11): 1029-1034.[41] Peirce SM, Price RJ, Skalak TC. Spatial and temporal control of angiogenesis and arterialization using focal application of VEGF164 and Ang-1. Am J Physiol Heart Circ Pysiol. 2004; 286(3): H918-925.[42] Ramoshebi LN, Ripamonti U. Osteogenic protein-1, a bone morphogenetic protein, induces angiogenesis in the chick chorioallantoic membrane and synergizes with basic fibroblast growth factor and transforming growth factor-beta 1. Anat Rec. 2000;259(1):97-107.[43] 李涛,王靖,杨惠林,等.活性维生素D促组织工程骨血管化[J]. 中国修复重建外科杂志,2007,21(10):1142-1146.[44] 范遗恩,乔建民,王日光,等.滑膜切除及血管植入治疗股骨头无菌性坏死[J].中华显微外科杂志,1988,11:206-207.[45] 毛宾尧,孔祥洪,张祥盛,等.血管束植入骨内的形态学研究[J]. 滨州医学院学报,1988,11(1):23-30.[46] 杨志明,解慧琪.显微外科技术在组织工程学研究中的地位与应用[J].中华显微外科杂志,2000,23(1):21-22.[47] Kavamura K, Yajima H, Ohgushi H, et al. Experimental study of vascularized tissue-engineered bone grafts. Plast Reconstr Surg. 2006;117(5):1471-1479.[48] Hokugo A, Kubo Y, Takahashi Y, et al. Prefabrication of vascularized bone graft using guided bone regeneration. Tissue Eng. 2004;10(7-8):978-986.[49] 王永刚,裴国献.血管束植入在组织工程骨血管化构建中的作用[J].解放军医学杂志,2007,32(1):26-28.[50] 曾宪利,裴国献,金丹,等.血管化组织工程骨修复猕猴胫骨缺损模型的建立和初步观察[J].中国创伤骨科杂志,2005,7(4):353-357.[51] 陈滨, 裴国献, 王珂, 等. 筋膜瓣促组织工程骨体内再血管化的实验研究[J]. 解放军医学杂志, 2002, 27(6): 482-484.[52] 樊征夫,杨志明.组织工程化人工骨组织移植修复长骨干缺损移植物体内血管化及血管化与成骨关系实验研究[C]. 第二届全国组织工程学术大会论文汇编,2000:378-386.[53] Vacanti CA, Vacanti JP. Bone and cartilage reconstruction with tissue engineering approaches. Otolaryngol Clin North Am. 1994;27(1):263-276.[54] Casabona F, Martin I, Muraqlia A, et al. Prefabricated engineered bone flaps: an experimental model of tissue reconstruction in plastic surgery. Plast Reconstr Surg. 1998; 101(3): 577-581.[55] Terheyden H, Jepsen S, Rueger DR. Mandibular reconstruction with a prefabricated vascularized bone graft using recombinant human osteogenic protein-1: an experimental study in miniature pigs. Part I: Prefabrication. Int J Oral Maxillofac Surg. 2001;30(5): 373-379. [56] Terheyden H, Warnke A, Dunsche S, et al. Mandibular reconstruction with prefabricated vascularized bone grafts using recombinant human osteogenic protein-1: an experimental study in miniature pigs. Part II: Transplantation. Int J Oral Maxillofac Surg. 2001;30(6): 469-478.[57] Terheyden H, Menzel C, Wang H, et al. Prefabrication of vascularized bone grafts using recombinant human osteogenic protein-1-part 3: dosage of rhOP-1, the use of external and internal scaffolds. Int J Oral Maxillofac Surg. 2004;33(2):164-172.[58] Finley JM, Acland RD, Wood MB. Revascularized periosteal grafts--a new method to produce functional new bone without bone grafting. Plast Reconstr Surg. 1978;61(1): 1-6.[59] 蒋祖言,柯新华,高奉浔.带血管的骨膜及同种脱钙骨移植治疗骨缺损的实验研究[J].中华创伤杂志,1991,7(3):150-152.[60] Levine JP, Bradley J. Bone morphogenetic protein promotes osteoinduction in performed hydroxyapatite in the rabbit. Ann Plast Surg. 1997;32(2):158-168.[61] 郑晓晖,陈振光,陶圣祥,等.显微外科技术预构组织工程骨血管化的比较[J]. 中华实验外科杂志,2008,25(2):214-217. |